Maryam Tabatabai, PharmD, associate vice president of clinical information, offers predictions about forthcoming drug approvals, the latest on a new voucher pilot, updated biosimilar guidance and more

What to expect at Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Live updates from AMCP Annual Meeting

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.

Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...

Research on GLP-1 drugs, specialty therapies and more helps improve affordability in health care

Studies on GLP-1 drugs, specialty therapies and more help improve affordability in health care

From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights

Managed Healthcare Executive: Prior authorization using integrated medical claims data helps diabetes patients get medications faster, with two-thirds processed automatically by July 2025 in this...

Prime Therapeutics Report shares more about single-treatment gene therapies and proper management

New report explores traditional, specialty therapy trend impact to employers

From next-gen CFTR modulators to gene therapy and real-world drug impact, cystic fibrosis care is constantly evolving. Maryam Tabatabai, PharmD, of Prime Therapeutics, explains how innovative...

Learn with Biosimilar Basics. Part 2 covers biosimilar naming conventions and other nomenclature including common drug pipeline content acronyms.

Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event

In the latest episode of the “Pharmacy Friends” podcast, join Prime’s research team for a preview of the industry-leading and award-winning research that will be presented at flagship industry event

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in National Harbor, Maryland

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans

Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings

Identifying and managing diabetes and weight loss therapies earns AMCP platinum award

Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.

13th annual report the preeminent source for medical benefit drug trend

Managed Healthcare Executive

Biobetters are just a nickname; they’re based on existing biologics but with a few key differences

For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories

Marquee event showcased new Prime, our energy, ambition and transformative journey

Event features discussions about health care industry trends, best practices and innovations

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

In this special episode of the Pharmacy Friends podcast, “Live at Specialty Summit ’24 – Connect. Elevate. Transform.,” we are on the road in New York City at our 21st annual Specialty Summit. More...

Annual meeting will feature industry research posters and educational sessions

Prime Therapeutics offers first-of-its-kind digital utilization management solution that pairs biomarker testing with targeted therapy drug selection

If you think about the rise of specialty drugs as a Category 5 hurricane, and the growth of gene therapies as an undersea earthquake, you can see the rising tsunami of drug spend looking to sweep...

Recent webinar featuring Prime Therapeutics experts shares some of the latest breakthrough therapies — including ADCs, BiTes and CAR-T treatments — and regulatory changes and market shifts that are...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

A strategic deep dive into the latest trend report from Prime Therapeutics reveals how oncology spend is evolving across benefits and what it means for cancer care management

As the efficacy and cost of these therapies become clear, so is the need for thoughtful managed care strategies, according to Prime Therapeutics thought leaders

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.

Pharmacy Friends In the latest episode of the “Pharmacy Friends” podcast, learn the latest insights on legislative trends, cutting-edge drug therapies and more from the 22nd annual event Alex Cook...

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

New approach aligns with long-standing biosimilar strategy

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

Managed Markets Insight & Technology (MMIT)

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.

Pharmacy Times

Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care

Becker’s Payer Issues

Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event

Discover the latest trends and emerging strategies to manage rising medical benefit specialty drug spend.

From cutting-edge system solutions to powerful stakeholder partnerships, the Medicaid Enterprise Systems Conference delivered key insights and connections that will shape health care modernization...

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

Specialty Pharmacy Continuum

Members on cancer care journey laud Prime’s integrated clinic-to-pharmacy experience

Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event